Antimicrobial Agents Practice Questions

Q: Which of the following is most effective against anaerobic streptococci?

Clindamycin. ### Explanation **Correct Option: B (Clindamycin)** Anaerobic streptococci (such as *Peptostreptococcus*) are common components of the normal flora of the mouth, skin, and GI tract, but they can cause serious deep-tissue infections. **Clindamycin** is the drug of choice because it has excellent penetration into abscesses and bone, and it specifically targets the 50S ribosomal subunit to inhibit protein synthesis. It is highly effective against most Gram-positive anaerobes and is frequently used for infections "above the diaphragm" (e.g., aspiration pneumonia, dental abscesses) where anaerobic streptococci are prevalent. **Incorrect Options:** * **A. Penicillin:** While many anaerobic streptococci remain sensitive to Penicillin, resistance is increasing due to the production of beta-lactamases by co-infecting organisms in polymicrobial infections. Clindamycin is generally considered more reliable in clinical practice for established anaerobic infections. * **C. Vancomycin:** Vancomycin is primarily reserved for aerobic Gram-positive infections like MRSA. While it has some activity against anaerobes, it is not the first-line choice for anaerobic streptococci and has poor tissue penetration compared to Clindamycin. * **D. Erythromycin:** This macrolide has poor activity against many anaerobic strains and high rates of resistance, making it an unreliable choice for anaerobic infections. **High-Yield NEET-PG Pearls:** * **Rule of Thumb:** For anaerobes, use **Clindamycin** for infections "above the diaphragm" and **Metronidazole** for infections "below the diaphragm" (e.g., *B. fragilis*). * **Side Effect:** The most classic association for Clindamycin in exams is **Pseudomembranous colitis** caused by *Clostridioides difficile*. * **Mechanism:** Clindamycin is a Lincosamide that inhibits the **50S ribosomal subunit**, similar to Macrolides.

Q: Which one of the following drugs is used in the treatment of Toxoplasmosis?

Pyrimethamine. **Explanation:** **Pyrimethamine** is the correct answer because it is a potent dihydrofolate reductase (DHFR) inhibitor. In the treatment of **Toxoplasmosis** (caused by *Toxoplasma gondii*), it is considered the gold standard. It works synergistically with **Sulfadiazine** to block sequential steps in folic acid synthesis, effectively inhibiting the replication of the parasite. **Analysis of Options:** * **Pyrimethamine (Correct):** It is the drug of choice for both congenital and acquired toxoplasmosis. When used, it must be administered with **Leucovorin (Folinic acid)** to prevent bone marrow suppression (megaloblastic anemia), as it can affect human DHFR at high doses. * **Artesunate (Option A):** This is an artemisinin derivative used primarily as the first-line treatment for severe **Malaria**, not toxoplasmosis. * **Ciprofloxacin (Option B):** A fluoroquinolone that inhibits DNA gyrase. It is used for various bacterial infections (UTIs, enteric fever) but has no clinical role in treating *T. gondii*. * **Thiacetazone (Option C):** An older antitubercular drug rarely used today due to its association with severe skin reactions (Stevens-Johnson Syndrome), especially in HIV-positive patients. **NEET-PG High-Yield Pearls:** 1. **Standard Regimen:** Pyrimethamine + Sulfadiazine + Folinic acid. 2. **Alternative for Sulfa-allergic patients:** Pyrimethamine + **Clindamycin**. 3. **Pregnancy:** If toxoplasmosis is acquired during pregnancy, **Spiramycin** is used to prevent fetal transmission. If the fetus is already infected, the pyrimethamine-sulfadiazine combo is used (after the first trimester). 4. **Prophylaxis:** In HIV patients with CD4 counts <100 cells/µL, **Trimethoprim-Sulfamethoxazole (Cotrimoxazole)** is the drug of choice for prophylaxis.

Q: Multidrug-resistant S. typhi strains are resistant to all except:

Ciprofloxacin. **Explanation:** The emergence of **Multidrug-Resistant (MDR)** *Salmonella typhi* is a significant clinical challenge. By definition, MDR strains of *S. typhi* are those that have developed resistance to all three traditional first-line antimicrobial agents: **Chloramphenicol, Ampicillin, and Trimethoprim-Sulfamethoxazole (Septran/Cotrimoxazole).** **Why Ciprofloxacin is the correct answer:** Fluoroquinolones, such as **Ciprofloxacin**, became the treatment of choice for enteric fever following the widespread emergence of MDR strains in the 1990s. While "decreased susceptibility" to ciprofloxacin is now common (leading to the use of Ceftriaxone or Azithromycin), it is not part of the classic "MDR" definition. Therefore, MDR strains remain susceptible to Ciprofloxacin unless they are further classified as "Extensively Drug-Resistant" (XDR). **Analysis of Incorrect Options:** * **A, B, and D (Chloramphenicol, Ampicillin, Septran):** These are the "traditional" first-line drugs. Resistance to these three specific classes (Phenicols, Penicillins, and Sulfonamides) is the hallmark of MDR *S. typhi*, usually mediated by R-plasmids. **High-Yield Clinical Pearls for NEET-PG:** * **MDR *S. typhi*:** Resistant to Chloramphenicol + Ampicillin + Septran. * **XDR *S. typhi*:** Resistant to MDR drugs + Fluoroquinolones + 3rd Gen Cephalosporins. * **Current DOC:** For uncomplicated enteric fever, **Ceftriaxone** (IV) or **Azithromycin** (Oral) are now preferred due to rising Nalidixic acid resistance and fluoroquinolone failure. * **Carrier State:** **Amoxicillin** is used for urinary carriers; **Ciprofloxacin** or **Cholecystectomy** is used for biliary carriers.

Q: Which antifungal agent exhibits a bactericidal mode of action against dermatophyte infections in therapeutic doses?

Terbinafine. **Explanation:** The correct answer is **Terbinafine**. The distinction between fungistatic and fungicidal action is a high-yield concept in NEET-PG Pharmacology. **1. Why Terbinafine is Correct:** Terbinafine belongs to the **Allylamine** class. It works by inhibiting the enzyme **Squalene Epoxidase**, which is responsible for converting squalene to lanosterol. This mechanism leads to a dual effect: * **Fungistatic effect:** Deficiency of ergosterol (a key component of the fungal cell membrane). * **Fungicidal effect:** The intracellular accumulation of **squalene** is toxic to the fungal cell, leading to rapid cell death. In therapeutic doses, this makes terbinafine bactericidal (fungicidal) against dermatophytes. **2. Why Incorrect Options are Wrong:** * **Fluconazole, Itraconazole, and Ketoconazole (Options A, C, D):** These are **Azoles**. They inhibit the enzyme **14-α-demethylase**. While they also impair ergosterol synthesis, they do not cause the toxic accumulation of squalene. Consequently, azoles are generally **fungistatic** (they inhibit growth rather than killing the fungi directly) at standard therapeutic concentrations. **3. Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Terbinafine is the DOC for **Onychomycosis** (fungal nail infections) and Tinea capitis. * **Pharmacokinetics:** It is highly lipophilic and keratophilic, meaning it concentrates in skin, hair, and nails, remaining effective long after the treatment is stopped. * **Side Effects:** While generally safe, monitor for **hepatotoxicity** and taste disturbances (ageusia). * **Comparison:** Unlike Ketoconazole, Terbinafine does not inhibit Cytochrome P450 enzymes significantly, leading to fewer drug-drug interactions.

Q: What is the recommended chemoprophylaxis for pregnant females traveling to areas endemic for Plasmodium falciparum?

Chloroquine. **Explanation:** The primary goal of chemoprophylaxis in pregnancy is to provide effective protection against malaria while ensuring fetal safety. **Why Chloroquine is correct:** Chloroquine is considered the safest antimalarial drug during all trimesters of pregnancy. In areas where *Plasmodium falciparum* remains sensitive to it, Chloroquine is the drug of choice for prophylaxis. It does not possess teratogenic potential and has a long-established safety profile for both the mother and the fetus. **Why the other options are incorrect:** * **Primaquine:** It is strictly **contraindicated** in pregnancy. It can cross the placenta and cause life-threatening hemolysis in the fetus if the fetus is G6PD deficient (even if the mother is not). * **Doxycycline:** It is contraindicated in pregnancy (Category D). As a tetracycline, it can cause permanent discoloration of the fetus's teeth and inhibit bone growth. * **Amodiaquine:** While used in some treatment combinations (ACTs), it is not a standard first-line agent for prophylaxis in travelers due to a higher risk of hepatotoxicity and agranulocytosis compared to other agents. **High-Yield Clinical Pearls for NEET-PG:** 1. **Chloroquine-Resistant Areas:** If the traveler is going to a region with Chloroquine-resistant *P. falciparum*, **Mefloquine** is the recommended prophylactic agent for pregnant women (safe in all trimesters). 2. **Atovaquone-Proguanil:** Generally avoided in pregnancy due to lack of sufficient safety data. 3. **Treatment vs. Prophylaxis:** For the *treatment* of uncomplicated falciparum malaria in the 1st trimester, Quinine + Clindamycin is preferred; in the 2nd and 3rd trimesters, ACT (Artesunate + Lumefantrine) is the standard.

Q: All of the following statements regarding the development of resistance against penicillins is true EXCEPT?

Bacteria may develop alternate metabolic pathways.. **Explanation:** The development of bacterial resistance to penicillins primarily involves mechanisms that interfere with the drug's ability to inhibit cell wall synthesis. **Why Option C is the correct answer:** Penicillins act by inhibiting the cross-linking of peptidoglycan in the bacterial cell wall. Unlike Sulfonamides (which inhibit folic acid synthesis), penicillins do not target metabolic pathways. Therefore, **developing alternate metabolic pathways** is a mechanism of resistance associated with **Sulfonamides and Trimethoprim**, not penicillins. **Why the other options are incorrect:** * **Option A (Inactivating enzymes):** This is the most common mechanism. Bacteria produce **$\beta$-lactamases (penicillinases)** that hydrolyze the $\beta$-lactam ring, rendering the drug inactive (e.g., *Staphylococcus aureus*). * **Option B (Altered PBPs):** Bacteria can modify the target site (Penicillin Binding Proteins). This is the hallmark mechanism for **MRSA** (Methicillin-resistant *S. aureus*) and penicillin-resistant *Streptococcus pneumoniae*. * **Option D (Reduced Permeability):** Gram-negative bacteria can change the size or charge of **porin channels** in their outer membrane, preventing the drug from reaching the PBPs (common in *Pseudomonas*). **High-Yield Clinical Pearls for NEET-PG:** 1. **MRSA Resistance:** Mediated by the **mecA gene**, which encodes an altered PBP called **PBP2a**, which has a low affinity for $\beta$-lactams. 2. **$\beta$-lactamase Inhibitors:** Drugs like Clavulanic acid, Sulbactam, and Tazobactam are used to overcome resistance caused by penicillinases (Option A) but are ineffective against resistance caused by altered PBPs (Option B). 3. **Efflux Pumps:** Another mechanism where bacteria actively pump the drug out of the cell (common in Tetracycline resistance).

Q: An elderly patient with tubercular meningitis is not responding to the current treatment. A new combination of drugs needs to be prescribed for a prolonged period. Which one of the following drugs should not be prescribed in this case?

Dehydrostreptomycin. **Explanation:** The correct answer is **Dehydrostreptomycin** because of its high risk of irreversible toxicity, particularly in elderly patients requiring long-term therapy. **1. Why Dehydrostreptomycin is the Correct Answer:** Dehydrostreptomycin is an aminoglycoside derivative that was historically used for tuberculosis. However, it is significantly more **ototoxic** than Streptomycin, specifically causing profound and permanent **cochlear damage (deafness)**. In an elderly patient where renal clearance is often reduced, the risk of accumulation and toxicity is even higher. Furthermore, aminoglycosides generally have poor penetration into the Cerebrospinal Fluid (CSF) unless the meninges are severely inflamed. Due to its severe toxicity profile, it has been largely replaced by safer alternatives. **2. Why the other options are incorrect:** * **Rifampicin:** A bactericidal "first-line" drug and the backbone of TB meningitis treatment. It penetrates the CSF well when meninges are inflamed. * **Ofloxacin:** A fluoroquinolone often used as a "second-line" agent in drug-resistant TB or when first-line drugs are not tolerated. It has excellent CSF penetration. * **Pyrazinamide:** A crucial first-line drug that achieves CSF concentrations nearly equal to plasma concentrations, making it highly effective for tubercular meningitis. **NEET-PG High-Yield Pearls:** * **Drug of Choice for TB Meningitis:** The standard regimen is HRZE (Isoniazid, Rifampicin, Pyrazinamide, Ethambutol). * **CSF Penetration:** Pyrazinamide and Isoniazid have the best CSF penetration among anti-TB drugs. * **Ototoxicity:** Aminoglycosides cause ototoxicity by damaging hair cells; Streptomycin is more vestibulotoxic, while Amikacin and Dehydrostreptomycin are more cochleotoxic. * **Elderly Caution:** Always prioritize drugs with lower toxicity profiles in the elderly due to age-related decline in eighth cranial nerve function and renal reserve.

Q: Gynaecomastia is a side effect of which of the following medications?

Rifampicin. **Explanation:** The correct answer is **Rifampicin**. While several drugs are classically associated with gynaecomastia, in the context of this specific question, Rifampicin is the correct choice due to its unique metabolic effects. **1. Why Rifampicin is Correct:** Rifampicin is a potent **inducer of hepatic microsomal enzymes (Cytochrome P450)**. It increases the metabolic clearance of testosterone and other androgens. Additionally, it can alter the ratio of estrogens to androgens in the body. This hormonal imbalance leads to the development of gynaecomastia in some patients undergoing anti-tubercular therapy (ATT). **2. Analysis of Other Options:** * **Digitalis:** While chronic use of Digoxin can cause gynaecomastia (due to its steroid-like structure which can bind to estrogen receptors), it is less frequently tested in this specific context compared to anti-infectives. * **Ketoconazole:** This is a classic cause of gynaecomastia. It inhibits the enzyme **17,20-desmolase**, thereby blocking the synthesis of adrenal and gonadal steroids (testosterone). * **Spironolactone:** This is perhaps the most common cause of drug-induced gynaecomastia. It acts as a **competitive antagonist at androgen receptors** and inhibits testosterone synthesis. *Note: In many standard exams, Spironolactone and Ketoconazole are more common answers. However, if Rifampicin is marked as the key, it highlights the importance of recognizing enzyme induction as a mechanism for hormonal side effects.* **3. High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Gynaecomastia (DISCO):** **D**igoxin, **I**soniazid, **S**pironolactone, **C**imetidine, **O**estrogens/Ketoconazole. * **Rifampicin** is also famous for causing **orange-red discoloration** of body fluids (urine, sweat, tears). * **Ketoconazole** is unique among antifungals for its anti-androgenic side effects, often used off-label for Cushing’s syndrome or prostate cancer.

Q: Which antibiotic can cause respiratory failure when used in patients with myasthenia gravis?

Telithromycin. **Explanation:** **Telithromycin**, a ketolide antibiotic derived from macrolides, is notorious for causing severe, life-threatening exacerbations of **Myasthenia Gravis (MG)**. The underlying mechanism involves the drug’s ability to block nicotinic acetylcholine receptors at the neuromuscular junction (NMJ). In patients with MG, who already have a reduced number of functional receptors, this blockade can precipitate a "myasthenic crisis," leading to acute respiratory failure. Consequently, the FDA has issued a **Black Box Warning** contraindicating its use in MG patients. **Analysis of Incorrect Options:** * **B. Clindamycin:** While lincosamides can theoretically potentiate neuromuscular blockade, they are not classically associated with the rapid, severe respiratory failure seen with Telithromycin in MG. * **C. Linezolid:** An oxazolidinone primarily known for causing bone marrow suppression (thrombocytopenia) and weak MAO inhibition (risk of Serotonin Syndrome). It does not significantly affect the NMJ. * **D. Tetracycline:** These can occasionally worsen MG by chelating calcium (required for ACh release), but they are far less potent in this regard than ketolides or aminoglycosides. **High-Yield Clinical Pearls for NEET-PG:** * **Aminoglycosides** (e.g., Gentamicin) are the most common class of antibiotics to avoid in MG as they inhibit the pre-synaptic release of Acetylcholine. * **Fluoroquinolones** (e.g., Ciprofloxacin) also carry a black box warning for MG exacerbation. * **Ketolides vs. Macrolides:** Telithromycin is structurally similar to Erythromycin but has a higher affinity for the NMJ receptors, making it significantly more dangerous for MG patients.

Question 1

Which of the following is most effective against anaerobic streptococci?

Accepted Answer

Clindamycin

Answer

Penicillin

Answer

Vancomycin

Answer

Erythromycin

Question 2

Which one of the following drugs is used in the treatment of Toxoplasmosis?

Accepted Answer

Pyrimethamine

Answer

Aensenuate

Answer

Ciprofloxacin

Answer

Thiacetazone

Question 3

Multidrug-resistant S. typhi strains are resistant to all except:

Accepted Answer

Ciprofloxacin

Answer

Chloramphenicol

Answer

Ampicillin

Answer

Septran

Question 4

Which antifungal agent exhibits a bactericidal mode of action against dermatophyte infections in therapeutic doses?

Accepted Answer

Terbinafine

Answer

Fluconazole

Answer

Itraconazole

Answer

Ketoconazole

Question 5

What is the recommended chemoprophylaxis for pregnant females traveling to areas endemic for Plasmodium falciparum?

Accepted Answer

Chloroquine

Answer

Primaquine

Answer

Doxycycline

Answer

Amodiaquine

Question 6

What is the recommended treatment for ventilator-associated pneumonia (VAP) caused by multidrug-resistant Acinetobacter baumannii?

Accepted Answer

Colistin

Answer

Quinupristin and dalfopristin

Answer

Lavendamycin

Answer

Tedizolid

Question 7

All of the following statements regarding the development of resistance against penicillins is true EXCEPT?

Accepted Answer

Bacteria may develop alternate metabolic pathways.

Answer

Bacteria may develop inactivating enzymes called penicillinases.

Answer

Bacteria may develop altered penicillin binding proteins.

Answer

Bacteria may become less permeable to penicillins.

Question 8

An elderly patient with tubercular meningitis is not responding to the current treatment. A new combination of drugs needs to be prescribed for a prolonged period. Which one of the following drugs should not be prescribed in this case?

Accepted Answer

Dehydrostreptomycin

Answer

Rifampicin

Answer

Ofloxacin

Answer

Pyrazinamide

Question 9

Gynaecomastia is a side effect of which of the following medications?

Accepted Answer

Rifampicin

Answer

Digitalis

Answer

Ketoconazole

Answer

Spironolactone

Question 10

Which antibiotic can cause respiratory failure when used in patients with myasthenia gravis?

Accepted Answer

Telithromycin

Answer

Clindamycin

Answer

Linezolid

Answer

Tetracycline

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?